Durable complete response in renal cell carcinoma clinical trials.

Pilié, Patrick G; Jonasch, Eric

Pilié, Patrick G; Jonasch, Eric.

Afiliação

Pilié PG; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jonasch E; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: ejonasch@mdanderson.org.

Lancet ; 393(10189): 2362-2364, 2019 06 15.

Article em En | MEDLINE | ID: mdl-31079937

Assuntos

Carcinoma de Células Renais; Neoplasias Renais; Anticorpos Monoclonais; Anticorpos Monoclonais Humanizados; Bevacizumab; Humanos; Sunitinibe

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google